FIELD: medicine.
SUBSTANCE: use of the nucleic acid based GATA-3 inactivation for treating a patient suffering Th2-induced asthma, wherein (i) the amount of eosinophils in blood is 3 % or more, and/or (ii) the amount of eosinophils in blood is 350·106/l or more, and/or (iii) the fractional expired nitrogen oxide is 40 billion-1 or more.
EFFECT: technical result is a more pronounced therapeutic effect on both phases (and early and late allergic reaction) of the asthmatic response after provoking an allergen of the patients with the declared indicators.
14 cl, 9 dwg, 7 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS FOR DIAGNOSING AND TREATING RELATED TO TH2 INHIBITION | 2011 |
|
RU2578468C2 |
| DIAGNOSTICS AND TREATMENT METHODS ASSOCIATED WITH TH2 INHIBITION | 2011 |
|
RU2737245C2 |
| METHOD FOR DIAGNOSING MOLECULAR PHENOTYPE OF PATIENTS SUFFERING FROM DISEASES ACCOMPANIED BY CHRONIC INFLAMMATION | 2013 |
|
RU2672595C2 |
| COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING ASTHMA | 2009 |
|
RU2607569C2 |
| METHODS FOR TREATMENT OR PREVENTION OF ASTHMA BY ADMINISTERING IL-4R ANTAGONIST | 2013 |
|
RU2690675C2 |
| METHODS FOR TREATMENT OR PREVENTION OF ASTHMA BY ADMINISTRATION OF IL-4R ANTAGONIST | 2018 |
|
RU2793745C2 |
| METHOD FOR ALLERGIC BRONCHIAL ASTHMA TREATMENT, BASED ON CYTOKINES IL-4 AND IL-13 GENES EXPRESSION INHIBITION USING SIRNA MOLECULES | 2016 |
|
RU2615463C1 |
| METHODS OF TREATING CHRONIC SINUSITIS WITH NASAL POLYPS BY ADMINISTERING IL-4R ANTAGONIST | 2015 |
|
RU2734490C2 |
| COMPOSITION FOR INTERLEUKINE-4 CYTOKINE GENE SILENCING | 2014 |
|
RU2563989C1 |
| METHOD OF TREATMENT OF BRONCHIAL ASTHMA | 2017 |
|
RU2652752C1 |
